Neurology
- DISEASE INDICATIONS: Spinal Muscular Atrophy
- MANUFACTURER: Biogen Idec Ltd
- USAGE: Intrathecal Injection
- MEDICINE APPROVED BY:
- European Medical Agency (EMA)
- Food and Drug Administration (FDA)
- Health Canada
- Therapeutic Goods Administration (TGA)
- Medsafe (NZ)
Spinraza, also known as Nusinersen, represents a groundbreaking advancement in the treatment of spinal muscular atrophy (SMA), a rare genetic disorder affecting motor neurons in the spinal cord.
Read more